- Home
- ROG vs MNKD Comparison
ROG vs MNKD Comparison
Compare ROG & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROG
- MNKD
- Stock Information
- Founded
- ROG 1832
- MNKD 1991
- Country
- ROG United States
- MNKD United States
- Employees
- ROG N/A
- MNKD N/A
- Industry
- ROG Industrial Machinery/Components
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- ROG Technology
- MNKD Health Care
- Exchange
- ROG Nasdaq
- MNKD Nasdaq
- Market Cap
- ROG 1.2B
- MNKD 1.4B
- IPO Year
- ROG N/A
- MNKD 2004
- Fundamental
- Price
- ROG $66.56
- MNKD $4.15
- Analyst Decision
- ROG Strong Buy
- MNKD Strong Buy
- Analyst Count
- ROG 2
- MNKD 5
- Target Price
- ROG $85.00
- MNKD $9.40
- AVG Volume (30 Days)
- ROG 201.7K
- MNKD 1.9M
- Earning Date
- ROG 07-24-2025
- MNKD 05-08-2025
- Dividend Yield
- ROG N/A
- MNKD N/A
- EPS Growth
- ROG N/A
- MNKD 228.27
- EPS
- ROG 0.90
- MNKD 0.10
- Revenue
- ROG $807,200,000.00
- MNKD $297,595,000.00
- Revenue This Year
- ROG N/A
- MNKD $14.36
- Revenue Next Year
- ROG $8.95
- MNKD $13.36
- P/E Ratio
- ROG $74.02
- MNKD $40.01
- Revenue Growth
- ROG N/A
- MNKD 32.50
- 52 Week Low
- ROG $51.43
- MNKD $4.05
- 52 Week High
- ROG $134.07
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- ROG 51.64
- MNKD 37.04
- Support Level
- ROG $65.19
- MNKD $4.07
- Resistance Level
- ROG $68.22
- MNKD $4.25
- Average True Range (ATR)
- ROG 1.39
- MNKD 0.16
- MACD
- ROG -0.15
- MNKD -0.03
- Stochastic Oscillator
- ROG 22.53
- MNKD 12.82
About ROG Rogers Corporation
Rogers Corporation designs develop and manufacture engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: Advanced Electronics Solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and Other, which consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.